间皮素作为癌症免疫治疗的生物标志物和治疗靶点
Mesothelin as Biomarker and Therapeutic Target for Immunotherapy in Cancer.
癌症仍是一个关键的全球健康问题，原因在于发现晚、耐药和高死亡率。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
胃癌免疫治疗：科学计量学与临床试验综述
英文原题：Gastric cancer immunotherapy: A scientometric and clinical trial review.
查看英文原题
Gastric cancer immunotherapy: A scientometric and clinical trial review.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
中文摘要
这封信旨在引起您对最近一篇关于胃癌（GC）免疫治疗的综合科学计量学和临床试验综述的兴趣。我们的研究回顾了GC领域免疫治疗的最新进展，并强调了其作为GC治疗的新前景。我们的研究揭示了我国在该领域的领先地位，以及免疫检查点抑制剂、细胞免疫治疗和疫苗等新治疗策略。这些综合发现凸显了免疫治疗在改善胃癌患者生存率和生活质量方面的潜力。我们相信，这项研究将为GC治疗领域的未来方向提供重要指导。
展开英文摘要原文
This letter is intended to arouse your interest in a recent review of comprehensive scientometrics and clinical trials on immunotherapy for gastric cancer (GC).
Our study reviews recent advances in immunotherapy in the field of GC and highlights its new prospects as a treatment for GC.
Our research reveals China's leadership in this field, as well as new therapeutic strategies such as immune checkpoint inhibitors, cellular immunotherapy, and vaccines. The combined findings highlight the potential of immunotherapy to improve survival and quality of life in patients with stomach cancer.
We believe that this study will provide important guidance for the future direction of the GC treatment field.
论文信息
- 作者
- Du QC、Wang XY、Yu H
- 第一作者单位
- Thoracic Surgery, Shanghai Xuhui Central Hospital, Shanghai 200031, China.China
- 通讯作者单位
- Department of General Surgery, Shanghai Fourth People's Hospital Affiliated to Tongji University School of Medicine, Shanghai 200434, China. luckyyuhua@163.com.China
- 期刊
- World journal of gastroenterology2024 Jan 14
- 原文标识
- PubMed 38312117 · DOI 10.3748/wjg.v30.i2.196
在 PubMed 查看 → 出版商原文（DOI） 全文 PDF（PMC）· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →